Shares of Innophos Holdings Inc. (NASDAQ:IPHS) were down 3% during mid-day trading on Wednesday . The company traded as low as $40.34 and last traded at $40.76, with a volume of 91,437 shares changing hands. The stock had previously closed at $42.00.

Separately, Zacks Investment Research raised Innophos Holdings from a “sell” rating to a “hold” rating in a research report on Tuesday, May 3rd.

The stock’s 50 day moving average price is $39.77 and its 200 day moving average price is $32.63. The stock has a market cap of $784.35 million and a P/E ratio of 29.69.

Innophos Holdings (NASDAQ:IPHS) last announced its quarterly earnings data on Wednesday, April 27th. The company reported $0.66 EPS for the quarter, beating the Zacks’ consensus estimate of $0.42 by $0.24. The company had revenue of $189.60 million for the quarter, compared to analysts’ expectations of $189.90 million. During the same period in the previous year, the firm posted $0.55 earnings per share. The business’s revenue for the quarter was down 6.0% on a year-over-year basis. On average, equities research analysts expect that Innophos Holdings Inc. will post $2.52 EPS for the current year.

In other Innophos Holdings news, Director Robert J. Zatta bought 1,000 shares of the firm’s stock in a transaction on Tuesday, May 24th. The stock was bought at an average cost of $37.11 per share, with a total value of $37,110.00. Following the completion of the transaction, the director now directly owns 4,351 shares of the company’s stock, valued at approximately $161,465.61. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, VP Joseph Golowski sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 22nd. The stock was sold at an average price of $40.46, for a total transaction of $202,300.00. Following the completion of the sale, the vice president now directly owns 28,069 shares of the company’s stock, valued at $1,135,671.74. The disclosure for this sale can be found here.

Other hedge funds have bought and sold shares of the company. California State Teachers Retirement System increased its stake in Innophos Holdings by 1.5% in the fourth quarter. California State Teachers Retirement System now owns 36,423 shares of the company’s stock valued at $1,056,000 after buying an additional 539 shares in the last quarter. Rhumbline Advisers increased its stake in Innophos Holdings by 2.9% in the fourth quarter. Rhumbline Advisers now owns 44,905 shares of the company’s stock valued at $1,301,000 after buying an additional 1,245 shares in the last quarter. Robeco Institutional Asset Management B.V. increased its stake in Innophos Holdings by 3.0% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 49,144 shares of the company’s stock valued at $1,424,000 after buying an additional 1,444 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in Innophos Holdings during the fourth quarter valued at approximately $1,444,000. Finally, Nationwide Fund Advisors increased its stake in Innophos Holdings by 31.9% in the fourth quarter. Nationwide Fund Advisors now owns 87,940 shares of the company’s stock valued at $2,549,000 after buying an additional 21,245 shares in the last quarter.

Innophos Holdings, Inc is a producer of performance-critical and nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. Bioactive mineral ingredients are mineral based ingredients for food, beverage and dietary supplement end markets that are manufactured to be readily digestible.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.